FDA advisory committee has recommended a booster dose of Moderna’s COVID-19 vaccine

BREAKING NEWS: FDA advisory committee unanimously recommended booster dose of Moderna’s COVID-19 vaccine for those over 65 and at high risk due to underlying conditions or their job

  • FDA advisory committee has voted to recommend approval of Covid booster shots from Moderna’s vaccine
  • Boosters shots are only approved for people 65 and older who are at high risk due to their job










An advisory committee of the U.S. Food and Drug Administration (FDA) has voted to recommend approval of booster doses of Moderna’s COVID-19.

The boosters are only approved for older adults 65 and older and those who are at high risk of developing a severe case of the virus due to underlying conditions.

It comes almost exactly one month after the Vaccines and Related Biological Products Advisory Committee (VRBPAC) approved boosters for the Pfizer-BioNTech vaccine

The FDA advisory committee has voted to recommend the approval of Covid booster shots from Moderna’s vaccine. Pictured: A health worker holds a vial of Moderna COVID-19 vaccine in New York City, January 2021

In August, the White House announced that COVID-19 vaccine booster shots would be rolled out to all Americans beginning September 20.

At the time, the Biden administration published studies citing declining immunity and the ability of the Delta variant to cause breakthrough infections.

However, officials from the FDA and the Centers for Disease Control and Prevention (CDC) pushed back, saying there was not enough evidence that the vaccines were declining in efficacy.

This led to Pfizer’s vaccine boosters not being rolled out until September 22 – after the target rollout date – and only for specific groups, just like Moderma.

Next, Moderna’s booster injection must be approved by the FDA and approved by the Centers for Disease Control and Prevention (CDC) advisory committee.

This is a latest news item and will be updated.

.